[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349933-105":59,"doc-detail-349933-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-relevance-of-specific-til-cd4-cd8-and-foxp3-t-cell-infiltrates-in-triple-negative-breast-cancer-short-and-long-term-outcomes","Prognostic relevance of specific TIL (CD4+, CD8+, and FOXP3 + T-cell infiltrates) in triple-negative breast cancer - short-and long-term outcomes","","Triple-negative breast cancer is a heterogeneous malignancy representing 15% of breast cancers, with high tumor immunogenicity and a tumor microenvironment that strongly shapes disease progression and patient outcomes. A study of 30 TNBC tissue samples characterized specific tumor-infiltrating lymphocyte subsets. Immunohistochemistry on tissue microarrays, supported by digital quantification, linked CD4+, CD8+, and FOXP3+ infiltrates with pathologic complete response, disease-free survival, and clinical outcomes, identifying associations for immediate prognosis and a trend toward improved long-term outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-relevance-of-specific-til-cd4-cd8-and-foxp3-t-cell-infiltrates-in-triple-negative-breast-cancer-short-and-long-term-outcomes/349933/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-relevance-of-specific-til-cd4-cd8-and-foxp3-t-cell-infiltrates-in-triple-negative-breast-cancer-short-and-long-term-outcomes/349933.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were tumor-infiltrating lymphocytes (TIL) measured in this study?","Question",{"text":112,"@type":113},"TIL were assessed by immunohistochemistry on tissue microarrays and complemented by digital analysis for standardized quantification.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which immune cell subset was associated with short-term outcomes like pCR?",{"text":117,"@type":113},"Higher CD4+ T-cell levels were significantly associated with achieving pathologic complete response (pCR).",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find regarding long-term outcomes such as disease-free survival (DFS)?",{"text":121,"@type":113},"Higher levels of CD4+, CD8+, and FOXP3+ T cells showed a non-significant tendency toward improved disease-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349933,1790924285,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Breast Cancer (2026) 33:386–395  \n[https://doi.org/10.1007/s12282-025-01819-y](https://doi.org/10.1007/s12282-025-01819-y)  \nORIGINAL ARTICLE  \nPrognostic relevance of specific TIL (CD4+, CD8+, and FOXP3 + T-cell infiltrates) in triple-negative breast cancer: short-and long-term outcomes  \nOlga Caramelo1 · Vânia Almeida2,3 · Ana Fidalgo4 · Augusta Cipriano2 · Teresa Almeida-Santos1,3  \nReceived: 10 August 2025 / Accepted: 26 December 2025 / Published online: 7 January 2026 © The Author(s) 2026  \nAbstract  \nBackground Breast cancer is a heterogeneous malignant disease that remains as one of the most prevalent cancers globally. Triple negative breast cancer (TNBC) accounts for 15% of the total of breast cancers and presents high tumor immunogenicity and a tumor microenvironment that plays a critical role in disease progression and patient outcomes.  \nMethods This study evaluated a total of 30 tissue samples from female patients with TNBC, to characterize specific immune cells within the tumor tissue and investigate their relationship with short (pathological complete response, pCR), long (disease-free survival, DFS) and clinical outcomes. Tumor-infiltrating lymphocytes (TIL) were assessed by immunohistochemistry (IHC) on tissue microarrays (TMA), complemented by digital analysis for standardized quantification.  \nResults Our results highlight the influence of CD4⁺ T cells on short-term outcomes: high CD4⁺ T-cell levels were significantly associated with achieving pCR. High CD8⁺ T-cell levels were also significantly associated with axillary lymph node negativity.Regarding long-term outcomes, higher CD4⁺, CD8⁺ and FOXP3⁺ T-cell levels showed a non-significant tendency toward improved DFS.  \nConclusions These findings suggest that high levels of CD4 + T cells and CD8 + T cells are positive predictors of immediate, long-term prognosis and clinical prognosis in patients with TNBC. This study enhances the understanding on the immunological interests in specific subtypes of TIL and identifies potential biomarkers that could drive advancements in precision medicine for breast cancer management.  \nKeywords Breast cancer · Immune cells · TIL · T cells · CD4 + T cells · CD8 + T cells · T regs · FOXP3 + cells  \nIntroduction  \nApproximately 15% of breast cancer cases are diagnosed as triple negative breast cancer (TNBC), which is recognized as a highly heterogenous disease [1] . Often TNBC exhibits a biologically aggressive behavior, resulting in a poor  \n􀀍 Olga Caramelo [olgalgcaramelo@gmail.com](olgalgcaramelo@gmail.com)  \n1 Department of Gynecology, Unidade Local de Saúde de Coimbra, Coimbra, Portugal  \n2 Department of Pathology, Unidade Local de Saúde de Coimbra, Coimbra, Portugal  \n3 Faculty of Medicine, University of Coimbra, Coimbra, Portugal  \n4 Immunethep, Cantanhede, Portugal  \nprognosis with a higher tendency to metastasize compared to other breast cancer subtypes [2, 3] .  \nUntil recently, chemotherapy was the only systemic treatment option for this subtype of breast cancer, posing significant challenges due to the exclusion of effective therapies such as hormone therapy and anti-HER2 agents [4] .  \nThe 5-year survival rate of TNBC is significantly lower when comparing to hormone receptor-positive breast cancer [5] . However, in the last decade substantial research has focused on improving the prognosis of TNBC, and newer treatment options, particularly immunotherapy, are being implemented in clinical practice [5] .  \nThe progression of breast cancer is complex and results from the interaction between tumor cells and components of the tumor microenvironment. Immune cells within this microenvironment play a critical role in the initiation and progression of breast cancer, as they can either promote or  \ninhibit tumor development. Analyzing the immune response within tumor tissue can aid in predicting disease outcomesand planning treatment strategies. Recent research has emphasized that TIL significantly influence breast cancer man","cbCaiv6k2TGRAvxG","https://ap.wps.com/l/cbCaiv6k2TGRAvxG","pdf",1123664,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"How were tumor-infiltrating lymphocytes (TIL) measured in this study?\",\"answer\":\"TIL were assessed by immunohistochemistry on tissue microarrays and complemented by digital analysis for standardized quantification.\"},{\"question\":\"Which immune cell subset was associated with short-term outcomes like pCR?\",\"answer\":\"Higher CD4+ T-cell levels were significantly associated with achieving pathologic complete response (pCR).\"},{\"question\":\"What did the study find regarding long-term outcomes such as disease-free survival (DFS)?\",\"answer\":\"Higher levels of CD4+, CD8+, and FOXP3+ T cells showed a non-significant tendency toward improved disease-free survival.\"}]","Prognostic relevance of specific TIL (CD4+, CD8+, and FOXP3 + T-cell infiltrates) in triple-negative breast cancer - short-and long-term outcomes | PDF",1790086324,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f7a3f07675740167301f329c7a1db48.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4025a41ef20ff55e6a71c6364b192fd.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23a6c23e79b921b7595489bbee0b6b26.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f20f6d0dbbe31d5381f3e2161fb516b2.webp",980,1301]